Do Psychedelics Mimic Psychosis? Perspectives on Similarities and Differences from Individuals with Lived Experience of Psychosis and Psychedelics
This qualitative study (n=19) of people with non-affective psychotic disorders who had used psychedelics found that, although there were some overlaps in altered thinking and meaning-making, most participants felt psychedelic experiences were not closely similar to psychosis. The authors conclude that psychedelics may be poor models of many psychotic symptoms, and that describing psychedelic effects as broadly psychosis-like may be misleading.
Authors
- Peter Hendricks
- Christopher Nicholas
- Heith Copes
Published
Abstract
Despite a long-standing interest in the potential similarities between psychedelic and psychotic experiences, no recent research has systematically explored the subjective overlap between these states in individuals who have experienced both. To provide rich accounts of potential overlaps and distinctions, we conducted semi-structured interviews with 19 individuals diagnosed with non-affective psychotic disorders who had used psychedelics. Participants described perceived similarities and differences between the acute effects of psychedelics and their experiences during psychosis. The study used reflexive thematic analysis to analyze the transcripts. Participants identified several points of contrast, including sensory alterations, emotional experience, altered thinking, meaning attribution, sense of control, and self experience. Although some similarities were acknowledged, particularly in terms of altered thinking and meaning attribution, most participants reported that psychedelic experiences did not closely resemble their experiences with psychosis. When asked which drug most resembled their psychotic symptoms, the majority endorsed cannabis, followed by dissociative anesthetics and stimulants. Psychedelics may not accurately model many symptoms of psychosis despite impacting similar domains of experience. These findings have implications for potential tolerability studies of psychedelics in people with psychotic disorders and suggest that interpreting psychedelic-induced experiences as broadly psychosis-like may be misleading.
Research Summary of 'Do Psychedelics Mimic Psychosis? Perspectives on Similarities and Differences from Individuals with Lived Experience of Psychosis and Psychedelics'
Blossom's Take
Psychedelics were originally seen as compounds that mimicked psychosis. That is, within the scientific community, after encountering LSD (and psilocybin) through Hofmann and Sandoz. Now, over half a century later, this interview study brings this concept before the current scientific standards and finds it lacking in precision (noting cannabis, dissociative anesthetics, and stimulants were all closer matches).
Introduction
Non-affective psychotic disorders such as schizophrenia have long been compared with the acute effects of serotonergic psychedelics because both can alter perception, thought, and self-experience. Earlier work often relied on indirect or historical comparisons, and while some studies suggested psychedelics can induce psychosis-like phenomena, it remained unclear how similar these states actually feel to people who have experienced both. The paper also notes that current psychedelic trials usually exclude people with personal or family histories of psychotic disorders, partly because psychedelics are assumed to be strongly psychotomimetic, yet that assumption has not been well examined from a lived-experience perspective. M. and colleagues therefore set out to explore, through qualitative interviews, how individuals with lived experience of non-affective psychotic disorders and psychedelic use describe similarities and differences between the two states. The study aimed to clarify whether psychedelic experiences are subjectively perceived as psychosis-like, which features overlap, and what this might mean for future tolerability studies, clinical support, and broader interpretations of psychedelics as psychotomimetics.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Topic
- Authors
- APA Citation
Dourron, H. M., Bradley, M. K., Copes, H., Nicholas, C. R., Turner, J. A., Allen-Clark, G., & Hendricks, P. S. (2026). Do Psychedelics Mimic Psychosis? Perspectives on Similarities and Differences from Individuals with Lived Experience of Psychosis and Psychedelics. International Journal of Mental Health and Addiction, 1-22.
References (22)
Papers cited by this study that are also in Blossom
Argyri, E. K., Evans, J., Luke, D. et al. · SSRN (2024)
Brouwer, A., Carhart-Harris, R. L. · Journal of Psychopharmacology (2020)
Carhart-Harris, R. L., Brugger, S., Nutt, D. J. et al. · Journal of Psychopharmacology (2013)
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M. et al. · Psychological Medicine (2016)
Dourron, H. M., Strauss, C., Hendricks, P. S. · Pharmacological Reviews (2022)
Evans, J., Robinson, O., Ketzitzidou-Argyri, E. et al. · PLOS ONE (2023)
Gashi, L., Sandberg, S., Pedersen, W. · International Journal of Drug Policy (2021)
Geyer, M. A., Vollenweider, F. X. · Trends in Pharmacological Sciences (2008)
Gouzoulis-Mayfrank, E., Heekeren, K., Neukirch, A. et al. · Pharmacopsychiatry (2005)
Johnson, M. W., Hendricks, P. S., Barrett, F. S. et al. · Pharmacology and Therapeutics (2019)
Show all 22 referencesShow fewer
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Torre, J. T. L., Gallo, J., Mahammadli, M. et al. · Journal of Psychedelic Studies (2024)
La Torre, J. T., Mahammadli, M., Faber, S. et al. · International Journal of Mental Health and Addiction (2023)
Leptourgos, P., Fortier-Davy, M., Carhart-Harris, R. L. et al. · Schizophrenia Bulletin (2020)
Osmond, H. · Annals of the New York Academy of Sciences (2010)
Sabé, M., Sulstarova, A., Glangetas, A. et al. · Molecular Psychiatry (2024)
Simonsson, O., Goldberg, S. B., Chambers, R. et al. · Psychopharmacology (2023)
Simonsson, O., Hendricks, P. S., Chambers, R. et al. · Journal of Affective Disorders (2023)
Simonsson, O., Mosing, M. A., Osika, W. et al. · JAMA Psychiatry (2024)
Timmermann, C., Vollenweider, F. X. · Trends in Cognitive Sciences (2023)
Wießner, I., Falchi, M., Palhano-Fontes, F. et al. · Psychological Medicine (2021)
Wolff, M., Evens, R., Mertens, L. J. et al. · Frontiers in Psychiatry (2020)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.